Gut Microbes Could Play a Protective Role Against Chemotherapy Side Effects
Emerging research suggests gut bacteria can reduce chemotherapy side effects, potentially leading to probiotic-based treatments to improve cancer therapy tolerability.
Recent research from the University of California, San Francisco, indicates that gut microbiota may have a significant impact on how patients tolerate chemotherapy treatments. Chemotherapy, essential for cancer treatment, is known to disrupt the natural balance of microbes in the digestive system, often leading to side effects such as nausea, vomiting, and nerve discomfort. However, scientists have discovered that certain bacteria in the gut can help mitigate these adverse effects.
The study focused on colorectal cancer patients undergoing treatment with fluoropyrimidine drugs. Findings revealed that individuals with less diverse gut microbiomes experienced fewer beneficial bacteria capable of breaking down chemotherapy drugs into harmless byproducts. These bacteria essentially act as biological agents that can absorb and chemically modify chemotherapy agents, reducing their toxicity.
Furthermore, researchers observed that measuring specific bacterial populations could predict the severity of side effects. Mice experiments demonstrated that introducing these beneficial microbes improved symptoms of severe chemotherapy toxicity, suggesting potential for probiotic therapies in humans.
A second related study uncovered that some gut bacteria produce vitamin K2, a compound linked to the protection against nerve-related side effects such as numbness and tingling. Patients with higher levels of these bacteria, especially nonpathogenic E. coli strains, reported fewer side effects. Administration of vitamin K2 to mice further supported its role in alleviating chemotherapy-induced discomfort.
This research highlights the critical relationship between the gut microbiome and drug toxicity. Better understanding might lead to new strategies for managing chemotherapy side effects, including targeted probiotics or microbiome modulation. Such approaches could improve treatment outcomes and quality of life for cancer patients.
Source: https://medicalxpress.com/news/2025-05-gut-microbes-patients-chemotherapy-side.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Breakthrough Clinical Trial Shows Therapeutic Plasma Exchange Can Rejuvenate Biological Age
A groundbreaking clinical trial reveals that therapeutic plasma exchange combined with IVIG can reduce biological age by over two years, highlighting new potential for aging interventions and longevity research.
US Cancer Survivors Reach 18.6 Million and Projected to Surpass 22 Million by 2035
The U.S. cancer survivor population is projected to grow from 18.6 million in 2025 to over 22 million by 2035, highlighting the need for equitable care and survivorship support.
